Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation THT 2024

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Presenter: Maria Rosa Costanzo

March 06, 2024

Presentation THT 2024

Cardiac Pulmonary Nerve Stimulation Improves Outcomes of Patients with Acute Decompensated Heart Failure: Results of the STOP-ADHF Pilot Study

Presenter: Sitaramesh Emani

March 05, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

Advertisement

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Cardiac Pulmonary Nerve Stimulation Improves Outcomes of Patients with Acute Decompensated Heart Failure: Results of the STOP-ADHF Pilot Study

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content